Nadunolimab Plus Pembrolizumab Shows Potential in Solid Tumors

Cantargia announced the publication of clinical trial results in Investigational New Drugs, showing the potential of nadunolimab combined with pembrol...
Home/KnloSights/Clinical Trial Updates/Nadunolimab Plus Pembrolizumab Shows Potential in Solid Tumors